Sign in to view content

Year 1 Time to Mobility Test Completion in a Voretigene Neparvovec-rzyl Trial in Subjects With RPE65 Mutation–Associated Inherited Retinal Disease

Julia A. Haller, MD

Video
Published 2018

Related

SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6
Michael S. Ip, MD
Annual Meeting Talks
2018
Post-Hoc Fellow Eye Analyses Support SAKURA Program Findings on Vitreous Haze, Visual Acuity and Macular Edema in Noninfectious Uveitis
Pauline T. Merrill, MD, FASRS
On Demand Cases, Courses, and Papers
2018
Vitreous Biomarkers for Alzheimer’s Disease in Patients Undergoing Vitrectomy and Cognitive Function Assessment
Manju L. Subramanian, MD
Annual Meeting Talks
2018

Category: Inherited retinal diseases

See more